News Features When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles Todd Neale September 28, 2021
News Daily News Even as COVID-19 Care Improved in NYC, Troponin Still Signaled Higher Mortality Caitlin E. Cox September 28, 2021
News Daily News Heterozygous FH Diagnosed Late, Remains Undertreated Michael O'Riordan September 13, 2021
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021
News Conference News ESC 2021 ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients Todd Neale August 29, 2021
News Conference News ESC 2021 MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk Shelley Wood August 28, 2021
News Conference News ESC 2021 SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI Michael O'Riordan August 27, 2021
News Daily News Uptick in ‘Implausible’ Cancers Reported After ARB Recalls L.A. McKeown August 20, 2021
News Daily News Endpoint Reporting in Medical Journals Needs to Be Revamped: Review Michael O'Riordan August 17, 2021
News Daily News One in Six HF Patients Delay or Forego Care, Inflating Costs Shelley Wood August 12, 2021
News Daily News ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study Michael O'Riordan July 27, 2021
News Daily News Complete Revascularization Best for Most ACS Patients With MVD Michael O'Riordan June 25, 2021
News Daily News US Studies Ease Concerns About Downstream Testing With hs-Troponin Todd Neale June 22, 2021